Skip to main content
Clinical Trials/ACTRN12607000113459
ACTRN12607000113459
Not yet recruiting
Phase 1

A randomised phase III study to evaluate the effects of methotrexate in the treatment of women with an ectopic pregnancy to prevent the need for surgical intervention.

Associate Professor George Condous0 sites400 target enrollmentFebruary 8, 2007

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Ectopic pregnancy
Sponsor
Associate Professor George Condous
Enrollment
400
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Associate Professor George Condous

Eligibility Criteria

Inclusion Criteria

  • Pre\-menopausal women • Asymptomatic• Haemodynamically stable• Serum human chorionic gonadotrophin level (hCG) less than 3000 IU/L• No haemoperitoneum• Absence of fetal cardiac activity on TVS• No contraindication to the use of methotrexate• Normal liver and renal function.

Exclusion Criteria

  • In pain• Haemodynamically unstable• Serum hCG \> 3000 IU/L• Haemoperitoneum on TVS• Fetal cardiac activity on TVS• Co\-existing intrauterine pregnancy• Contraindication to the use of methotrexate• Abnormal liver or kidney function• Unable to attend for follow up clinic visits• Learning difficulties, patients under the age of 18 and other vulnerable groups, e.g. mental illness, dementia due to issues regarding informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials